Ledger.Open graph →
SEC Form D · filed March 23, 2020

i2O Therapeutics, Inc

Offering
$3.2M
Sold
$3.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SARATOGA, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Christopher Gagliardi · Saratoga, CADirectorKatie Ellias · Saratoga, CADirectorRavi Srinivasan · Saratoga, CAExec · DirectorSamir Mitragotri · Saratoga, CAExec · DirectorMatt Gohd · Dumfries, VADirectorMiguel Forbes · Dumfries, VAExec · DirectorClass VI Capital Partners, LP · STAMFORD, CTExec · DirectorDavid Stonehill · Dumfries, VADirectorAREX Capital Management, LP · New York, NYExec · DirectorAREX Capital GP, LLC · New York, NYDirectorAndrew J. Phillips · Boulder, CODirectorKarl Anderson · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗